These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 15025718)

  • 1. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
    Langbehn DR; Brinkman RR; Falush D; Paulsen JS; Hayden MR;
    Clin Genet; 2004 Apr; 65(4):267-77. PubMed ID: 15025718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Huntington's disease diagnostics: development of a standard reference material.
    Levin BC; Richie KL; Jakupciak JP
    Expert Rev Mol Diagn; 2006 Jul; 6(4):587-96. PubMed ID: 16824032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited CAG.CTG allele length is a major modifier of somatic mutation length variability in Huntington disease.
    Veitch NJ; Ennis M; McAbney JP; ; Shelbourne PF; Monckton DG
    DNA Repair (Amst); 2007 Jun; 6(6):789-96. PubMed ID: 17293170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular genetics of Huntington's disease].
    Goto J; Masuda N; Watanabe M; Kanazawa I
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1529-31. PubMed ID: 8752453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CAG repeat length on psychiatric disorders in Huntington's disease.
    Vassos E; Panas M; Kladi A; Vassilopoulos D
    J Psychiatr Res; 2008 Jun; 42(7):544-9. PubMed ID: 17610899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.
    Wexler NS; Lorimer J; Porter J; Gomez F; Moskowitz C; Shackell E; Marder K; Penchaszadeh G; Roberts SA; Gayán J; Brocklebank D; Cherny SS; Cardon LR; Gray J; Dlouhy SR; Wiktorski S; Hodes ME; Conneally PM; Penney JB; Gusella J; Cha JH; Irizarry M; Rosas D; Hersch S; Hollingsworth Z; MacDonald M; Young AB; Andresen JM; Housman DE; De Young MM; Bonilla E; Stillings T; Negrette A; Snodgrass SR; Martinez-Jaurrieta MD; Ramos-Arroyo MA; Bickham J; Ramos JS; Marshall F; Shoulson I; Rey GJ; Feigin A; Arnheim N; Acevedo-Cruz A; Acosta L; Alvir J; Fischbeck K; Thompson LM; Young A; Dure L; O'Brien CJ; Paulsen J; Brickman A; Krch D; Peery S; Hogarth P; Higgins DS; Landwehrmeyer B;
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3498-503. PubMed ID: 14993615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Huntington's chorea: clinical aspects, genetics and current diagnosis].
    Spiegel R
    Ther Umsch; 1995 Dec; 52(12):814-20. PubMed ID: 8539653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer simulation of expansions of DNA triplet repeats in the fragile X syndrome and Huntington's disease.
    Bat O; Kimmel M; Axelrod DE
    J Theor Biol; 1997 Sep; 188(1):53-67. PubMed ID: 9299309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.
    Kehoe P; Krawczak M; Harper PS; Owen MJ; Jones AL
    J Med Genet; 1999 Feb; 36(2):108-11. PubMed ID: 10051007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trinucleotide repeat length and rate of progression of Huntington's disease.
    Illarioshkin SN; Igarashi S; Onodera O; Markova ED; Nikolskaya NN; Tanaka H; Chabrashwili TZ; Insarova NG; Endo K; Ivanova-Smolenskaya IA
    Ann Neurol; 1994 Oct; 36(4):630-5. PubMed ID: 7944295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of trinucleotide repeat expansion as a new mechanism of mutation in Huntington's chorea: theoretical and applied aspects].
    Illarioshkin SN; Ivanova-Smolenskaia IA; Markova ED; Nikol'skaia NN; Chabrashvili TZ; Insarova NG
    Genetika; 1996 Jan; 32(1):103-9. PubMed ID: 8647411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAG mutation effect on rate of progression in Huntington's disease.
    Squitieri F; Cannella M; Simonelli M
    Neurol Sci; 2002 Sep; 23 Suppl 2():S107-8. PubMed ID: 12548366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of CAG repeat length with clinical progression in Huntington disease.
    Rosenblatt A; Liang KY; Zhou H; Abbott MH; Gourley LM; Margolis RL; Brandt J; Ross CA
    Neurology; 2006 Apr; 66(7):1016-20. PubMed ID: 16606912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships of the 2642 deletion polymorphism (delta 2642) in the huntingtin gene with the CAG repeat expansion length and age at onset of the disease.
    Lucotte G; Gérard N; Roubertoux P; Schmitt I; Riess O
    Genet Couns; 1996; 7(4):297-302. PubMed ID: 8985734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the Huntington's disease gene in New Zealand.
    Whitefield JE; Williams L; Snow K; Dixon J; Winship I; Stapleton PM; Faull RM; Love DR
    N Z Med J; 1996 Feb; 109(1015):27-30. PubMed ID: 8606810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles.
    Semaka A; Creighton S; Warby S; Hayden MR
    Clin Genet; 2006 Oct; 70(4):283-94. PubMed ID: 16965319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hOGG1 Ser326Cys polymorphism and Huntington's disease.
    Coppedè F; Migheli F; Ceravolo R; Bregant E; Rocchi A; Petrozzi L; Unti E; Lonigro R; Siciliano G; Migliore L
    Toxicology; 2010 Dec; 278(2):199-203. PubMed ID: 19857538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4p16.3 haplotype modifying age at onset of Huntington disease.
    Nørremølle A; Budtz-Jørgensen E; Fenger K; Nielsen JE; Sørensen SA; Hasholt L
    Clin Genet; 2009 Mar; 75(3):244-50. PubMed ID: 19250382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the correlates of intermediate CAG repeats in Huntington disease.
    Ha AD; Jankovic J
    Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.